<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">diaendo</journal-id><journal-title-group><journal-title xml:lang="ru">Сахарный диабет</journal-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0351</issn><issn pub-type="epub">2072-0378</issn><publisher><publisher-name>Endocrinology research centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/DM12656</article-id><article-id custom-type="elpub" pub-id-type="custom">diaendo-12656</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Original Studies</subject></subj-group></article-categories><title-group><article-title>Уровень гликемии на 60-й минуте стандартного перорального глюкозотолерантного теста как новый критерий оценки инсулиносекреции у детей с ожирением</article-title><trans-title-group xml:lang="en"><trans-title>One-hour postload plasma glucose levels as a new criterion for assessing insulin secretion in obese children</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9299-1053</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Васюкова</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasyukova</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Васюкова Ольга Владимировна, к.м.н.; eLibrary SPIN: 6432-3934117036, Москва, ул. Дмитрия Ульянова, д. 11телефон: 89168504805</p></bio><bio xml:lang="en"><p>Olga V. Vasyukova, MD, PhD; eLibrary SPIN: 6432-393411 Dm. Ulyanova street, 117036, Moscow</p></bio><email xlink:type="simple">o.vasyukova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9834-727X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Окороков</surname><given-names>П. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Okorokov</surname><given-names>P. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Окороков Павел Леонидович, к.м.н.; eLibrary SPIN: 6989-2620Москва</p></bio><bio xml:lang="en"><p>Pavel L. Okorokov, MD, PhD; eLibrary SPIN: 6989-2620Moscow</p></bio><email xlink:type="simple">pokorokov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5507-4627</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петеркова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Peterkova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петеркова Валентина Александровна, д.м.н., профессор, академик РАН; eLibrary SPIN: 4009-2463Москва</p></bio><bio xml:lang="en"><p>Valentina A. Peterkova, MD, PhD; eLibrary SPIN: 4009-2463Moscow</p></bio><email xlink:type="simple">peterkovava@hotmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский центр эндокринологии</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>23</day><month>01</month><year>2021</year></pub-date><volume>23</volume><issue>6</issue><fpage>523</fpage><lpage>531</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Васюкова О.В., Окороков П.Л., Петеркова В.А., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Васюкова О.В., Окороков П.Л., Петеркова В.А.</copyright-holder><copyright-holder xml:lang="en">Vasyukova O.V., Okorokov P.L., Peterkova V.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.dia-endojournals.ru/jour/article/view/12656">https://www.dia-endojournals.ru/jour/article/view/12656</self-uri><abstract><sec><title>ОБОСНОВАНИЕ</title><p>ОБОСНОВАНИЕ. Распространенность сахарного диабета 2 типа (СД2) и связанных с ним дисгликемических состояний, повышающих риск развития диабета, продолжает увеличиваться во всем мире, главным образом из-за постоянно растущей частоты ожирения. Раннее выявление лиц, подверженных риску развития СД2, имеет важное значение как для профилактики данного заболевания, так и связанных с ним кардиометаболических осложнений.</p></sec><sec><title>ЦЕЛЬ</title><p>ЦЕЛЬ. Изучить особенности инсулиносекреции и инсулиночувствительности у детей и подростков с ожирением в зависимости от уровня гликемии на 60-й минуте (Гл60) стандартного перорального глюкозотолерантного теста (ПГТТ).</p></sec><sec><title>МЕТОДЫ</title><p>МЕТОДЫ. В открытое сравнительное одномоментное исследование включены 613 детей в возрасте от 6 до 17,9 года c конституционально-экзогенным ожирением, разделенных на 2 группы: 173 пациента с уровнем Гл60 ≥8,6 ммоль/л и 440 детей с уровнем Гл60 &lt;8,6 ммоль/л. Проведен скрининг дислипидемии, неалкогольной жировой болезни печени, артериальной гипертензии, нарушения толерантности к глюкозе (НТГ). Инсулиносекрецию оценивали по максимальному (ИРИ max), среднему уровню (ИРИ сред) инсулина в ходе ПГТТ и инсулиногенному индексу (ИГИ), инсулинорезистентность (ИР) — по индексу Matsuda.</p></sec><sec><title>РЕЗУЛЬТАТЫ</title><p>РЕЗУЛЬТАТЫ. Группы сопоставимы по возрасту, полу, стадии полового развития и степени ожирения. Дети с Гл60 ≥8,6 ммоль/л отличаются большей ИР (Matsuda 2,8±2,3 vs 3,5±2,2, р&lt;0,01), гиперинсулинемией (ИРИ max 190,0±59,5 vs 157,1±63,4 мкЕд/мл, р&lt;0,001, ИРИ сред 115,3±59,7 vs 90,2±54,1 мкЕд/мл, p&lt;0,001) и вместе с тем низким значением ИГИ (1,84±1,62 vs 2,61±1,3, р&lt;0,01), что свидетельствует о нарушении первой фазы секреции инсулина. Наименьшие значения ИГИ выявлены у пациентов группы «Гл60 ≥8,6» с НТГ (1,4±0,9). Также пациенты с Гл60 ≥8,6 ммоль/л характеризуются большей частотой метаболических осложнений в виде нарушения толерантности к глюкозе, артериальной гипертензии, жирового гепатоза и стеатогепатита.</p></sec><sec><title>ЗАКЛЮЧЕНИЕ</title><p>ЗАКЛЮЧЕНИЕ. Уровень Гл60 ≥8,6 ммоль/л может быть использован в качестве дополнительного маркера метаболически осложненного ожирения у детей и подростков с высоким риском прогрессирования нарушений углеводного обмена.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>BACKGROUND</title><p>BACKGROUND: Incidence of Type 2 Diabetes Mellitus (T2DM) and associated dysglycemic conditions, increasing the risk of diabetes development, continues to rise worldwide, most notably due to ever-growing obesity rate. Early identification of the persons who are exposed to the risk of T2DM development holds much significance for prevention of both this disease and associated cardiometabolic complications.</p></sec><sec><title>AIM</title><p>AIM: To study characteristics of insulin secretion and insulin sensitivity among obese children and adolescents versus the glycemic level 60 minutes (GL60) after the standard oral glucose tolerance test (OGTT).</p></sec><sec><title>METHODS</title><p>METHODS: This open-label comparative cross-sectional study involved 613 children in the age between 6 and 17.9 years old with constitutive-exogenous obesity, divided into 2 groups: 173 patients with GL60 level ≥ 8.6 mmol/L and 440 children with GL60 level &lt; 8.6 mmol/L. They underwent a screening for dyslipidemia, non-alcoholic fatty liver disease, arterial hypertension and impaired glucose tolerance (IGT). Insulin secretion was evaluated on the basis of maximal (IRI max), average level (IRI avg) of insulin in the course of OGTT and insulinogenic index (IGI), insulin resistance (IG) — by Matsuda index.</p></sec><sec><title>RESULTS</title><p>RESULTS: The groups were comparable in the terms of age, sex, sexual maturation stage and obesity level. Children with GL60 level ≥ 8.6 mmol/L were characterized by higher IR (Matsuda 2.8 ± 2.3 vs 3.5 ± 2.2, р &lt; 0.01), hyperinsulinemia (IRI max 190.0 ± 59.5 vs 157.1 ± 63.4 μU/ml, р &lt; 0.001, IRI avg 115.3 ± 59.7 vs 90.2 ± 54.1 μU/ml, p &lt; 0.001) along with low IGI value (1.84 ± 1.62 vs 2.61 ± 1.3, р &lt; 0.01), which is indicative of the first phase insulin secretion impairment. The lowest IGI values were found among the "GL60 level ≥ 8.6 mmol/L" group patients with IGT (1.4 ± 0.9). Besides, the patients with GL60 level ≥ 8.6 mmol/L are characterized by the higher rate of metabolic complications in the form of impaired glucose tolerance, arterial hypertension, fatty hepatosis and steatohepatitis.</p></sec><sec><title>CONCLUSIONS</title><p>CONCLUSIONS: GL60 level ≥ 8.6 mmol/L can be used as an additional marker for metabolically complicated obesity among children and adolescents with a high risk of the carbohydrate metabolism disorder development.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ПГТТ</kwd><kwd>секреция инсулина</kwd><kwd>инсулинорезистентность</kwd><kwd>ожирение</kwd><kwd>дети</kwd></kwd-group><kwd-group xml:lang="en"><kwd>OGTT</kwd><kwd>insulin secretion</kwd><kwd>insulin resistance</kwd><kwd>obesity</kwd><kwd>children</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Подготовка и публикация рукописи проведены в рамках выполнения Госзадания «Новые подходы к персонифицированному лечению ожирения у детей на основе исследований энергетического обмена, функционального резерва бета-клеток, секреции адипокинов, миокинов и специфических шаперонов», регистрационный номер АААА-А20-120011790172-9.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Gregg EW. Are Children the Future of Type 2 Diabetes Prevention? N Engl J Med. 2010;362(6):548-550. https://doi.org/10.1056/NEJMe0912192</mixed-citation><mixed-citation xml:lang="en">Gregg EW. Are Children the Future of Type 2 Diabetes Prevention? N Engl J Med. 2010;362(6):548-550. https://doi.org/10.1056/NEJMe0912192</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Gungor N, Bacha F, Saad R, et al. Youth Type 2 Diabetes: Insulin resistance, β-cell failure, or both? Diabetes Care. 2005;28(3):638-644. https://doi.org/10.2337/diacare.28.3.638</mixed-citation><mixed-citation xml:lang="en">Gungor N, Bacha F, Saad R, et al. Youth Type 2 Diabetes: Insulin resistance, β-cell failure, or both? Diabetes Care. 2005;28(3):638-644. https://doi.org/10.2337/diacare.28.3.638</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305-312. https://doi.org/10.1016/j.diabres.2007.05.004</mixed-citation><mixed-citation xml:lang="en">Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract. 2007;78(3):305-312. https://doi.org/10.1016/j.diabres.2007.05.004</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Gungor N, Bacha F, Saad R, et al. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes — 2019. Diabetes Care. 2019;42(1):S13-S28. https://doi.org/10.2337/dc19-S002</mixed-citation><mixed-citation xml:lang="en">Gungor N, Bacha F, Saad R, et al. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes — 2019. Diabetes Care. 2019;42(1):S13-S28. https://doi.org/10.2337/dc19-S002</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Abdul-Ghani MA, DeFronzo RA. Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes. Diabetes Care. 2009;32(2):S194-S198. https://doi.org/10.2337/dc09-S309</mixed-citation><mixed-citation xml:lang="en">Abdul-Ghani MA, DeFronzo RA. Plasma Glucose Concentration and Prediction of Future Risk of Type 2 Diabetes. Diabetes Care. 2009;32(2):S194-S198. https://doi.org/10.2337/dc09-S309</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19(9):708-723. https://doi.org/10.1046/j.1464-5491.2002.00835.x</mixed-citation><mixed-citation xml:lang="en">Unwin N, Shaw J, Zimmet P, Alberti KGMM. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002;19(9):708-723. https://doi.org/10.1046/j.1464-5491.2002.00835.x</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA. One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes. Diabetes Care. 2008;31(8):1650-1655. https://doi.org/10.2337/dc08-0225</mixed-citation><mixed-citation xml:lang="en">Abdul-Ghani MA, Abdul-Ghani T, Ali N, DeFronzo RA. One-Hour Plasma Glucose Concentration and the Metabolic Syndrome Identify Subjects at High Risk for Future Type 2 Diabetes. Diabetes Care. 2008;31(8):1650-1655. https://doi.org/10.2337/dc08-0225</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Abdul-Ghani MA, Lyssenko V, et al. Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study. Diabetes Care. 2009;32(2):281-286. https://doi.org/10.2337/dc08-1264</mixed-citation><mixed-citation xml:lang="en">Abdul-Ghani MA, Lyssenko V, et al. Fasting Versus Postload Plasma Glucose Concentration and the Risk for Future Type 2 Diabetes: Results from the Botnia Study. Diabetes Care. 2009;32(2):281-286. https://doi.org/10.2337/dc08-1264</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Priya M, Anjana RM, Chiwanga FS, et al. 1-Hour Venous Plasma Glucose and Incident Prediabetes and Diabetes in Asian Indians. Diabetes Technol Ther. 2013;15(6):497-502. https://doi.org/10.1089/dia.2013.0025</mixed-citation><mixed-citation xml:lang="en">Priya M, Anjana RM, Chiwanga FS, et al. 1-Hour Venous Plasma Glucose and Incident Prediabetes and Diabetes in Asian Indians. Diabetes Technol Ther. 2013;15(6):497-502. https://doi.org/10.1089/dia.2013.0025</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorentino TV, Marini MA, Andreozzi F, et al. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015;100(10):3744-3751. https://doi.org/10.1210/jc.2015-2573</mixed-citation><mixed-citation xml:lang="en">Fiorentino TV, Marini MA, Andreozzi F, et al. One-Hour Postload Hyperglycemia Is a Stronger Predictor of Type 2 Diabetes Than Impaired Fasting Glucose. J Clin Endocrinol Metab. 2015;100(10):3744-3751. https://doi.org/10.1210/jc.2015-2573</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorentino TV, Marini MA, Succurro E, et al. One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes. J Clin Endocrinol Metab. 2018;103(9):3131-3143. https://doi.org/10.1210/jc.2018-00468</mixed-citation><mixed-citation xml:lang="en">Fiorentino TV, Marini MA, Succurro E, et al. One-Hour Postload Hyperglycemia: Implications for Prediction and Prevention of Type 2 Diabetes. J Clin Endocrinol Metab. 2018;103(9):3131-3143. https://doi.org/10.1210/jc.2018-00468</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Succurro E, Arturi F, Lugarà M, et al. One-Hour Postload Plasma Glucose Levels Are Associated with Kidney Dysfunction. Clin J Am Soc Nephrol. 2010;5(11):1922-1927. https://doi.org/10.2215/CJN.03240410</mixed-citation><mixed-citation xml:lang="en">Succurro E, Arturi F, Lugarà M, et al. One-Hour Postload Plasma Glucose Levels Are Associated with Kidney Dysfunction. Clin J Am Soc Nephrol. 2010;5(11):1922-1927. https://doi.org/10.2215/CJN.03240410</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Alyass A, Almgren P, Akerlund M, et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58(1):87-97. https://doi.org/10.1007/s00125-014-3390-x</mixed-citation><mixed-citation xml:lang="en">Alyass A, Almgren P, Akerlund M, et al. Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts. Diabetologia. 2015;58(1):87-97. https://doi.org/10.1007/s00125-014-3390-x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Tfayli H, Jung Lee S, Bacha F, Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about β-cell function relative to insulin sensitivity in overweight/ obese children? Pediatr Diabetes. 2011;58(1):572-579. https://doi.org/10.1111/j.1399-5448.2011.00745.x</mixed-citation><mixed-citation xml:lang="en">Tfayli H, Jung Lee S, Bacha F, Arslanian S. One-hour plasma glucose concentration during the OGTT: what does it tell about β-cell function relative to insulin sensitivity in overweight/ obese children? Pediatr Diabetes. 2011;58(1):572-579. https://doi.org/10.1111/j.1399-5448.2011.00745.x</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Диагностика и лечение ожирения у детей и подростков. Федеральные клинические рекомендации (протоколы) по ведению детей с эндокринными заболеваниями / Под ред. И.И. Дедова, В.А. Петерковой. — М.: Практика; 2014. — С. 163-183.</mixed-citation><mixed-citation xml:lang="en">Diagnostika i lechenie ozhireniya u detei i podrostkov. Federal’nye klinicheskie rekomendatsii (protokoly) po vedeniyu detei s endokrinnymi zabolevaniyam. Ed. by Dedov II, Peterkova VA. Moscow: Praktika; 2014: Р. 163-183. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470. https://doi.org/10.2337/diacare.22.9.1462</mixed-citation><mixed-citation xml:lang="en">Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462-1470. https://doi.org/10.2337/diacare.22.9.1462</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Васюкова О.В. Инсулин, лептин, липиды и периферические ростовые факторы при ожирении у детей: Дисс. ... канд. мед. наук. — М.; 2006.</mixed-citation><mixed-citation xml:lang="en">Vasyukova OV. Insulin, leptin, lipidy i perifericheskie rostovye faktory pri ozhirenii u detei. [dissertation]. Moscow; 2006. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Phillips DIW, Clark PM, Hales CN, Osmond C. Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion. Diabet Med. 1994;11(3):286-292. https://doi.org/10.1111/j.1464-5491.1994.tb00273.x</mixed-citation><mixed-citation xml:lang="en">Phillips DIW, Clark PM, Hales CN, Osmond C. Understanding Oral Glucose Tolerance: Comparison of Glucose or Insulin Measurements During the Oral Glucose Tolerance Test with Specific Measurements of Insulin Resistance and Insulin Secretion. Diabet Med. 1994;11(3):286-292. https://doi.org/10.1111/j.1464-5491.1994.tb00273.x</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004. https://doi.org/10.1210/jc.2003-031503</mixed-citation><mixed-citation xml:lang="en">Yeckel CW, Weiss R, Dziura J, et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004. https://doi.org/10.1210/jc.2003-031503</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Nakagomi A, Sunami Y, Okada S, et al. Association between 1-h postload plasma glucose levels and arterial stiffness in normotensive subjects with normal glucose tolerance. Diabetes Vasc Dis Res. 2018;15(1):39-45. https://doi.org/10.1177/1479164117736509</mixed-citation><mixed-citation xml:lang="en">Nakagomi A, Sunami Y, Okada S, et al. Association between 1-h postload plasma glucose levels and arterial stiffness in normotensive subjects with normal glucose tolerance. Diabetes Vasc Dis Res. 2018;15(1):39-45. https://doi.org/10.1177/1479164117736509</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Bergman M, Chetrit A, Roth J, Dankner R. One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet Med. 2016;33(8):1060-1066. https://doi.org/10.1111/dme.13116</mixed-citation><mixed-citation xml:lang="en">Bergman M, Chetrit A, Roth J, Dankner R. One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel Study of Glucose Intolerance, Obesity and Hypertension. Diabet Med. 2016;33(8):1060-1066. https://doi.org/10.1111/dme.13116</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorentino TV, Sesti F, Andreozzi F, et al. Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions. Nutr Metab Cardiovasc Dis. 2016;26(5):439-441. https://doi.org/10.1016/j.numecd.2016.01.009</mixed-citation><mixed-citation xml:lang="en">Fiorentino TV, Sesti F, Andreozzi F, et al. Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions. Nutr Metab Cardiovasc Dis. 2016;26(5):439-441. https://doi.org/10.1016/j.numecd.2016.01.009</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Bardini G, Dicembrini I, Cresci B, Rotella CM. Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels. Diabetes Care. 2010;33(2):411-413. https://doi.org/10.2337/dc09-1342</mixed-citation><mixed-citation xml:lang="en">Bardini G, Dicembrini I, Cresci B, Rotella CM. Inflammation Markers and Metabolic Characteristics of Subjects With 1-h Plasma Glucose Levels. Diabetes Care. 2010;33(2):411-413. https://doi.org/10.2337/dc09-1342</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Bianchi C, Miccoli R, Trombetta M, et al. Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. J Clin Endocrinol Metab. 2013;98(5):2100-2105. https://doi.org/10.1210/jc.2012-3971</mixed-citation><mixed-citation xml:lang="en">Bianchi C, Miccoli R, Trombetta M, et al. Elevated 1-Hour Postload Plasma Glucose Levels Identify Subjects With Normal Glucose Tolerance but Impaired β-Cell Function, Insulin Resistance, and Worse Cardiovascular Risk Profile: The GENFIEV Study. J Clin Endocrinol Metab. 2013;98(5):2100-2105. https://doi.org/10.1210/jc.2012-3971</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Jagannathan R, Sevick MA, Li H, et al. Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine. 2016;52(1):172-175. https://doi.org/10.1007/s12020-015-0746-z</mixed-citation><mixed-citation xml:lang="en">Jagannathan R, Sevick MA, Li H, et al. Elevated 1-hour plasma glucose levels are associated with dysglycemia, impaired beta-cell function, and insulin sensitivity: a pilot study from a real world health care setting. Endocrine. 2016;52(1):172-175. https://doi.org/10.1007/s12020-015-0746-z</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Pareek M, Bhatt DL, Nielsen ML, et al. Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study. Diabetes Care. 2018;41(1):171-177. https://doi.org/10.2337/dc17-1351</mixed-citation><mixed-citation xml:lang="en">Pareek M, Bhatt DL, Nielsen ML, et al. Enhanced Predictive Capability of a 1-Hour Oral Glucose Tolerance Test: A Prospective Population-Based Cohort Study. Diabetes Care. 2018;41(1):171-177. https://doi.org/10.2337/dc17-1351</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JY, Goran MI, Toledo-Corral CM, et al. One-Hour Glucose During an Oral Glucose Challenge Prospectively Predicts -Cell Deterioration and Prediabetes in Obese Hispanic Youth. Diabetes Care. 2013;36(6):1681-1686. https://doi.org/10.2337/dc12-1861</mixed-citation><mixed-citation xml:lang="en">Kim JY, Goran MI, Toledo-Corral CM, et al. One-Hour Glucose During an Oral Glucose Challenge Prospectively Predicts -Cell Deterioration and Prediabetes in Obese Hispanic Youth. Diabetes Care. 2013;36(6):1681-1686. https://doi.org/10.2337/dc12-1861</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Marini MA, Succurro E, Frontoni S, et al. Insulin Sensitivity, β-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels. Diabetes Care. 2012;35(4):868-872. https://doi.org/10.2337/dc11-2181</mixed-citation><mixed-citation xml:lang="en">Marini MA, Succurro E, Frontoni S, et al. Insulin Sensitivity, β-Cell Function, and Incretin Effect in Individuals With Elevated 1-Hour Postload Plasma Glucose Levels. Diabetes Care. 2012;35(4):868-872. https://doi.org/10.2337/dc11-2181</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Serbis A, Giapros V, Challa A, et al. Elevated 1-hour postload plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile. Clin Endocrinol (Oxf ). 2018;89(6):757-764. https://doi.org/10.1111/cen.13859</mixed-citation><mixed-citation xml:lang="en">Serbis A, Giapros V, Challa A, et al. Elevated 1-hour postload plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile. Clin Endocrinol (Oxf ). 2018;89(6):757-764. https://doi.org/10.1111/cen.13859</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Marcovecchio ML, Bagordo M, Marisi E, et al. One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk. J Endocrinol Invest. 2017;40(7):771-778. https://doi.org/10.1007/s40618-017-0638-6</mixed-citation><mixed-citation xml:lang="en">Marcovecchio ML, Bagordo M, Marisi E, et al. One-hour post-load plasma glucose levels associated with decreased insulin sensitivity and secretion and early makers of cardiometabolic risk. J Endocrinol Invest. 2017;40(7):771-778. https://doi.org/10.1007/s40618-017-0638-6</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Manco M, Miraglia Del Giudice E, Spreghini MR, et al. 1-Hour plasma glucose in obese youth. Acta Diabetol. 2012;49(6):435-443. https://doi.org/10.1007/s00592-012-0384-3</mixed-citation><mixed-citation xml:lang="en">Manco M, Miraglia Del Giudice E, Spreghini MR, et al. 1-Hour plasma glucose in obese youth. Acta Diabetol. 2012;49(6):435-443. https://doi.org/10.1007/s00592-012-0384-3</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Marini MA, Frontoni S, Succurro E, et al. Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels. Eckel J, ed. PLoS One. 2013;8(10):e77440. https://doi.org/10.1371/journal.pone.0077440</mixed-citation><mixed-citation xml:lang="en">Marini MA, Frontoni S, Succurro E, et al. Decreased Insulin Clearance in Individuals with Elevated 1-h Post-Load Plasma Glucose Levels. Eckel J, ed. PLoS One. 2013;8(10):e77440. https://doi.org/10.1371/journal.pone.0077440</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Castaldo E, Sabato D, Lauro D, et al. Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLoS One. 2011. https://doi.org/10.1371/journal.pone.0028312</mixed-citation><mixed-citation xml:lang="en">Castaldo E, Sabato D, Lauro D, et al. Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLoS One. 2011. https://doi.org/10.1371/journal.pone.0028312</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Marathe CS, Rayner CK, Lange K, et al. Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance. Physiol Rep. 2017;5(4):e13122. https://doi.org/10.14814/phy2.13122</mixed-citation><mixed-citation xml:lang="en">Marathe CS, Rayner CK, Lange K, et al. Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance. Physiol Rep. 2017;5(4):e13122. https://doi.org/10.14814/phy2.13122</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Ferraris RP, Casirola DM, Vinnakota RR. Dietary Carbohydrate Enhances Intestinal Sugar Transport in Diabetic Mice. Diabetes. 1993;42(11):1579-1587. https://doi.org/10.2337/diab.42.11.1579</mixed-citation><mixed-citation xml:lang="en">Ferraris RP, Casirola DM, Vinnakota RR. Dietary Carbohydrate Enhances Intestinal Sugar Transport in Diabetic Mice. Diabetes. 1993;42(11):1579-1587. https://doi.org/10.2337/diab.42.11.1579</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorentino TV, Suraci E, Arcidiacono GP, et al. Duodenal Sodium/ Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. J Clin Endocrinol Metab. 2017;102(11):3979-3989. https://doi.org/10.1210/jc.2017-00348</mixed-citation><mixed-citation xml:lang="en">Fiorentino TV, Suraci E, Arcidiacono GP, et al. Duodenal Sodium/ Glucose Cotransporter 1 Expression Under Fasting Conditions Is Associated With Postload Hyperglycemia. J Clin Endocrinol Metab. 2017;102(11):3979-3989. https://doi.org/10.1210/jc.2017-00348</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Wright EM, Loo DDF, Hirayama BA. Biology of Human Sodium Glucose Transporters. Physiol Rev. 2011;91(2):733-794. https://doi.org/10.1152/physrev.00055.2009</mixed-citation><mixed-citation xml:lang="en">Wright EM, Loo DDF, Hirayama BA. Biology of Human Sodium Glucose Transporters. Physiol Rev. 2011;91(2):733-794. https://doi.org/10.1152/physrev.00055.2009</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Succurro E, Arturi F, Grembiale A, et al. One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutr Metab Cardiovasc Dis. 2011;21(9):713-718. https://doi.org/10.1016/j.numecd.2011.02.002</mixed-citation><mixed-citation xml:lang="en">Succurro E, Arturi F, Grembiale A, et al. One-hour post-load plasma glucose levels are associated with elevated liver enzymes. Nutr Metab Cardiovasc Dis. 2011;21(9):713-718. https://doi.org/10.1016/j.numecd.2011.02.002</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sesti G, Hribal ML, Fiorentino TV, et al. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. BMJ Open Diabetes Res Care. 2014;2(1):e000016. https://doi.org/10.1136/bmjdrc-2014-000016</mixed-citation><mixed-citation xml:lang="en">Sesti G, Hribal ML, Fiorentino TV, et al. Elevated 1 h postload plasma glucose levels identify adults with normal glucose tolerance but increased risk of non-alcoholic fatty liver disease. BMJ Open Diabetes Res Care. 2014;2(1):e000016. https://doi.org/10.1136/bmjdrc-2014-000016</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sesti G, Fiorentino TV, Succurro E, et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 2014. https://doi.org/10.1007/s00592-013-0539-x</mixed-citation><mixed-citation xml:lang="en">Sesti G, Fiorentino TV, Succurro E, et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol. 2014. https://doi.org/10.1007/s00592-013-0539-x</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Andreozzi F, Mannino GC, Perticone M, et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a proatherogenic lipid profile. Atherosclerosis. 2017;256:15-20. https://doi.org/10.1016/j.atherosclerosis.2016.11.020</mixed-citation><mixed-citation xml:lang="en">Andreozzi F, Mannino GC, Perticone M, et al. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a proatherogenic lipid profile. Atherosclerosis. 2017;256:15-20. https://doi.org/10.1016/j.atherosclerosis.2016.11.020</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka K, Kanazawa I, Yamaguchi T, Sugimoto T. One-hour post-load hyperglycemia by 75g oral glucose tolerance test as a novel risk factor of atherosclerosis. Endocr J. 2014;61(4):329-334. https://doi.org/10.1507/endocrj.EJ13-0370</mixed-citation><mixed-citation xml:lang="en">Tanaka K, Kanazawa I, Yamaguchi T, Sugimoto T. One-hour post-load hyperglycemia by 75g oral glucose tolerance test as a novel risk factor of atherosclerosis. Endocr J. 2014;61(4):329-334. https://doi.org/10.1507/endocrj.EJ13-0370</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">O’Leary DH, Polak JF, Kronmal RA, et al. Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340(1):14–22.</mixed-citation><mixed-citation xml:lang="en">O’Leary DH, Polak JF, Kronmal RA, et al. Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340(1):14–22.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness. J Am Coll Cardiol. 2010;55(13):1318-1327. https://doi.org/10.1016/j.jacc.2009.10.061</mixed-citation><mixed-citation xml:lang="en">Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness. J Am Coll Cardiol. 2010;55(13):1318-1327. https://doi.org/10.1016/j.jacc.2009.10.061</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Sciacqua A, Miceli S, Greco L, et al. One-Hour Postload Plasma Glucose Levels and Diastolic Function in Hypertensive Patients. Diabetes Care. 2011;34(10):2291-2296. https://doi.org/10.2337/dc11-0879</mixed-citation><mixed-citation xml:lang="en">Sciacqua A, Miceli S, Greco L, et al. One-Hour Postload Plasma Glucose Levels and Diastolic Function in Hypertensive Patients. Diabetes Care. 2011;34(10):2291-2296. https://doi.org/10.2337/dc11-0879</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Sciacqua A, Maio R, Miceli S, et al. Association between One-Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension. Manco M, ed. PLoS One. 2012;7(9):e44470. https://doi.org/10.1371/journal.pone.0044470</mixed-citation><mixed-citation xml:lang="en">Sciacqua A, Maio R, Miceli S, et al. Association between One-Hour Post-Load Plasma Glucose Levels and Vascular Stiffness in Essential Hypertension. Manco M, ed. PLoS One. 2012;7(9):e44470. https://doi.org/10.1371/journal.pone.0044470</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
